Intersect ENT

Intersect ENT

Employees:
300
Market Cap:
$775.61 million
Revenue:
$78.86 million
Net Income:
$-23.48 million
NASDAQ:
XENT

Intersect ENT (NASDAQ: XENT) is a publicly traded health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Wikipedia

Intersect ENT

Employees:
300
Market Cap:
$775.61 million
Revenue:
$78.86 million
Net Income:
$-23.48 million
NASDAQ:
XENT

Intersect ENT (NASDAQ: XENT) is a publicly traded health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Wikipedia

Sep 1, 4:38 PM

We will be at The American Rhinologic Society's 63rd Annual Meeting, which takes place on September 9th in Chicago. We hope to see you there!

Aug 3, 3:15 PM

The American Rhinologic Society Annual Meeting is coming up on September 8th in Chicago! We hope to see you there! bit.ly/2vz54iS

Jul 15, 1:30 PM

Great turnout this morning at Intersect ENT's breakfast symposium discussing the impact of local drug delivery on frontal sinus surgery at The American Rhinologic Society's Summer Sinus meeting. #summersinus2017

Jun 26, 9:03 PM

We're proud of Intersect ENT's many Wonder Women of medtech, including our CEO Lisa Earnhardt, who is featured in this list by Qmed News: goo.gl/j7ZTv5